Cargando…

Cationic crosslinked carbon dots-adjuvanted intranasal vaccine induces protective immunity against Omicron-included SARS-CoV-2 variants

Mucosal immunity plays a significant role in the first-line defense against viruses transmitted and infected through the respiratory system, such as SARS-CoV-2. However, the lack of effective and safe adjuvants currently limits the development of COVID-19 mucosal vaccines. In the current study, we p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lei, Hong, Alu, Aqu, Yang, Jingyun, He, Xi, He, Cai, Ren, Wenyan, Chen, Zimin, Hong, Weiqi, Chen, Li, He, Xuemei, Yang, Li, Li, Jiong, Wang, Zhenling, Wang, Wei, Wei, Yuquan, Lu, Shuaiyao, Lu, Guangwen, Song, Xiangrong, Wei, Xiawei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169129/ https://www.ncbi.nlm.nih.gov/pubmed/37160882 http://dx.doi.org/10.1038/s41467-023-38066-8

Ejemplares similares

Intranasal administration of a recombinant RBD vaccine induces long-term immunity against Omicron-included SARS-CoV-2 variants
por: Lei, Hong, et al.
Publicado: (2022)

A recombinant spike‐XBB.1.5 protein vaccine induces broad‐spectrum immune responses against XBB.1.5‐included Omicron variants of SARS‐CoV‐2
por: He, Cai, et al.
Publicado: (2023)

Low levels of neutralizing antibodies against XBB Omicron subvariants after BA.5 infection
por: Yang, Jingyun, et al.
Publicado: (2023)

Cationic nanocarriers as potent adjuvants for recombinant S-RBD vaccine of SARS-CoV-2
por: Lei, Hong, et al.
Publicado: (2020)

Intranasal COVID-19 vaccines: From bench to bed
por: Alu, Aqu, et al.
Publicado: (2022)

Spike protein of SARS‐CoV‐2 Omicron (B.1.1.529) variant has a reduced ability to induce the immune response
por: He, Cai, et al.
Publicado: (2022)

A self-assembled trimeric protein vaccine induces protective immunity against Omicron variant
por: He, Cai, et al.
Publicado: (2022)

A bivalent recombinant vaccine targeting the S1 protein induces neutralizing antibodies against both SARS‐CoV‐2 variants and wild‐type of the virus
por: He, Cai, et al.
Publicado: (2021)

Trimeric protein vaccine based on Beta variant elicits robust immune response against BA.4/5-included SARS-CoV-2 Omicron variants
por: He, Cai, et al.
Publicado: (2023)

SARS‐CoV‐2 Omicron variant: Characteristics and prevention
por: He, Xuemei, et al.
Publicado: (2021)

Heterologous vaccination with subunit protein vaccine induces a superior neutralizing capacity against BA.4/5‐included SARS‐CoV‐2 variants than homologous vaccination of mRNA vaccine
por: Peng, Dandan, et al.
Publicado: (2023)

BTK inhibitors in the treatment of hematological malignancies and inflammatory diseases: mechanisms and clinical studies
por: Alu, Aqu, et al.
Publicado: (2022)

The modulatory effect of high salt on immune cells and related diseases
por: Li, Xian, et al.
Publicado: (2022)

Inactivated SARS-CoV-2 induces acute respiratory distress syndrome in human ACE2-transgenic mice
por: Bi, Zhenfei, et al.
Publicado: (2021)

The role of lysosome in regulated necrosis
por: Alu, Aqu, et al.
Publicado: (2020)

cGAS-STING pathway in cancer biotherapy
por: Wang, Yang, et al.
Publicado: (2020)

The rapid rise of SARS‐CoV‐2 Omicron subvariants with immune evasion properties: XBB.1.5 and BQ.1.1 subvariants
por: Ao, Danyi, et al.
Publicado: (2023)

Biomaterial-assisted biotherapy: A brief review of biomaterials used in drug delivery, vaccine development, gene therapy, and stem cell therapy
por: Han, Xuejiao, et al.
Publicado: (2022)

Histones released by NETosis enhance the infectivity of SARS-CoV-2 by bridging the spike protein subunit 2 and sialic acid on host cells
por: Hong, Weiqi, et al.
Publicado: (2022)

A mouse model for SARS-CoV-2-induced acute respiratory distress syndrome
por: Hong, Weiqi, et al.
Publicado: (2021)

Immunological perspectives on the pathogenesis, diagnosis, prevention and treatment of COVID-19
por: Ni, Yanghong, et al.
Publicado: (2021)

JMJD6 in tumor-associated macrophage regulates macrophage polarization and cancer progression via STAT3/IL-10 axis
por: Chen, Siyuan, et al.
Publicado: (2023)

The challenges of COVID‐19 Delta variant: Prevention and vaccine development
por: He, Xuemei, et al.
Publicado: (2021)

TFAM deficiency in dendritic cells leads to mitochondrial dysfunction and enhanced antitumor immunity through cGAS-STING pathway
por: Lu, Tianqi, et al.
Publicado: (2023)

Correction: Spontaneous apoptosis of cells in therapeutic stem cell preparation exert immunomodulatory effects through release of phosphatidylserine
por: He, Xuemei, et al.
Publicado: (2022)

Spontaneous apoptosis of cells in therapeutic stem cell preparation exert immunomodulatory effects through release of phosphatidylserine
por: He, Xuemei, et al.
Publicado: (2021)

Animal models for SARS‐CoV‐2 infection and pathology
por: Bi, Zhenfei, et al.
Publicado: (2021)

SARS‐CoV‐2 Omicron variant: Immune escape and vaccine development
por: Ao, Danyi, et al.
Publicado: (2022)

S19W, T27W, and N330Y mutations in ACE2 enhance SARS-CoV-2 S-RBD binding toward both wild-type and antibody-resistant viruses and its molecular basis
por: Ye, Fei, et al.
Publicado: (2021)

Tripterin liposome relieves severe acute respiratory syndrome as a potent COVID-19 treatment
por: Que, Haiying, et al.
Publicado: (2022)

Targeting Myeloid-Derived Suppressor Cells for Premetastatic Niche Disruption After Tumor Resection
por: Tang, Fan, et al.
Publicado: (2020)

A novel heterologous receptor-binding domain dodecamer universal mRNA vaccine against SARS-CoV-2 variants
por: Qin, Shugang, et al.
Publicado: (2023)

The molecular mechanisms of MLKL-dependent and MLKL-independent necrosis
por: Li, Lu, et al.
Publicado: (2020)

Antitumor and Radiosensitization Effects of a CXCR2 Inhibitor in Nasopharyngeal Carcinoma
por: Liu, Xiaobei, et al.
Publicado: (2021)

Hyperprogression: A novel response pattern under immunotherapy
por: Han, Xue‐jiao, et al.
Publicado: (2020)

Application of Baculovirus Expression Vector System (BEVS) in Vaccine Development
por: Hong, Qiaonan, et al.
Publicado: (2023)

Targeted therapy for head and neck cancer: signaling pathways and clinical studies
por: Li, Qingfang, et al.
Publicado: (2023)

Opportunities and challenges in the nanoparticles for nucleic acid therapeutics: the first approval of an RNAi nanoparticle for treatment of a rare disease
por: Wei, Xiawei, et al.
Publicado: (2019)

The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis
por: Huang, Yuhe, et al.
Publicado: (2022)

Characterization of SARS-CoV-2 Omicron spike RBD reveals significantly decreased stability, severe evasion of neutralizing-antibody recognition but unaffected engagement by decoy ACE2 modified for enhanced RBD binding
por: Lin, Sheng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jgkdk14cehfapv84i8ofbv2nsg